| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $438.9M | -50.0% |
| R&D Expense | $44.6M | -80.8% |
| SG&A Expense | $135.6M | -49.0% |
| Operating Income | $153.1M | +1008.2% |
| Interest Expense | $45.3M | +16.3% |
| Pre-tax Income | $109.8M | +459.5% |
| Income Tax | -$28.6M | -200.9% |
| Net Income | -$295.9M | -433.5% |
| EPS (Basic) | -$2.83 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $114.6M | -43.0% |
| Accounts Receivable | $58.5M | -59.3% |
| Current Assets | $258.7M | -50.2% |
| Total Assets | $1.21B | -51.0% |
| Current Liabilities | $166.7M | -12.1% |
| Long-term Debt | $729.4M | -4.7% |
| Total Liabilities | $909.1M | -19.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $183.0M | -22.0% |
| Capital Expenditures | $12.6M | -9.8% |
| Investing Cash Flow | -$2.9M | +53.1% |
| Financing Cash Flow | -$263.3M | -34.1% |
| Free Cash Flow | $170.4M | -22.8% |
| -434.0% |
| EPS (Diluted) | -$2.75 | -418.9% |
| Stockholders' Equity |
| $301.4M |
| -77.7% |